Stocks News

LAST PRICE
878.4500
TODAY'S CHANGE (%)
Trending Down-4.8800 (-0.5525%)

Bid / Lots
878.7000/ 1
Ask / Lots
888.0000/ 1
Open / Previous Close
882.3300 / 883.3300
Day Range
Low 876.0000
High 884.6100
52 Week Range
Low 434.3400
High 885.0600
Volume
2,023,264
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Jun 14, 2024
- DJ Gilead Stock Gains. It's Trying to Get Into the Obesity Drug Game. -- Barrons.com, from 2:27PM ET on Friday Jun 14, 2024 by Dow Jones
  2:27PM ET on Friday Jun 14, 2024 by Dow Jones
  Companies Mentioned: GILD, LLY, NVO, AMGN
  
  By Jacob Sonenshine
  
  Gilead Sciences stock was climbing Friday on hopes that it would get into the obesity-drug game.
  
  GLP-1s, the technical name for the popular obesity drugs, has been one of the biggest drivers of pharmaceutical stocks in recent months. Have one, and there's a good chance your stock is higher; don't have one and it's difficult to get investors interested.
Jun 13, 2024
- DJ Lilly's Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP. -- WSJ, from 9:51PM ET on Thursday Jun 13, 2024 by Dow Jones
  9:51PM ET on Thursday Jun 13, 2024 by Dow Jones
  Companies Mentioned: LLY
  
  By Jessica Mendoza, Matt Kwong and Peter Loftus
  
  In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly, was on a West Coast college tour with his daughter when his phone rang.
- DJ Lilly's Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP. -- WSJ, from 9:00PM ET on Thursday Jun 13, 2024 by Dow Jones
  9:00PM ET on Thursday Jun 13, 2024 by Dow Jones
  Companies Mentioned: LLY
  
  By Jessica Mendoza, Matt Kwong and Peter Loftus
  
  In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly, was on a West Coast college tour with his daughter when his phone rang.
Jun 12, 2024
- Eli Lilly Gets FDA Approval for Selpercatinib to Treat Thyroid Cancer, from 3:47PM ET on Wednesday Jun 12, 2024 by MT Newswires
  3:47PM ET on Wednesday Jun 12, 2024 by MT Newswires
  Companies Mentioned: LLY
  03:47 PM EDT, 06/12/2024 (MT Newswires) -- Eli Lilly (LLY) received approval from the US Food and Drug Administration for selpercatinib to treat thyroid cancer in certain adult and pediatric patients two years and older, the regulator said Wednesday...
- Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan, from 1:53PM ET on Wednesday Jun 12, 2024 by MT Newswires
  1:53PM ET on Wednesday Jun 12, 2024 by MT Newswires
  Companies Mentioned: LLY, NVO
  01:53 PM EDT, 06/12/2024 (MT Newswires) -- Novo Nordisk (NVO) and Eli Lilly's (LLY) weight-loss drugs will be dropped from coverage after Blue Cross Blue Shield of Michigan has decided to stop covering GLP-1 obesity drugs under its fully insured lar...

Today
- CALQUENCE(R) (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial, from 12 hours ago by Business Wire
  12 hours ago by Business Wire
  Companies Mentioned: AZN
Jun 14, 2024
- AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer, from 4:37PM ET on Friday Jun 14, 2024 by MT Newswires
  4:37PM ET on Friday Jun 14, 2024 by MT Newswires
  Companies Mentioned: ABBV
- European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading, from 11:15AM ET on Friday Jun 14, 2024 by MT Newswires
  11:15AM ET on Friday Jun 14, 2024 by MT Newswires
  Companies Mentioned: NTZ, TRIB, NGG, SQNS, DAVA, GNFT, MREO, AZN, DBVT, CRH, CUK, CLLS, ADAP, EDAP
Jun 13, 2024
- AbbVie, FutureGen to Develop Potential Inflammatory Bowel Disease Treatment, from 8:44AM ET on Thursday Jun 13, 2024 by MT Newswires
  8:44AM ET on Thursday Jun 13, 2024 by MT Newswires
  Companies Mentioned: ABBV
Jun 12, 2024
- AstraZeneca Gets FDA Approval for Pediatric Type-2 Diabetes Control Drug, from 4:00PM ET on Wednesday Jun 12, 2024 by MT Newswires
  4:00PM ET on Wednesday Jun 12, 2024 by MT Newswires
  Companies Mentioned: AZN
Jun 11, 2024
- Alvotech Expands Alliance with STADA to Include Denosumab Biosimilar, from 5:26AM ET on Tuesday Jun 11, 2024 by MT Newswires
  5:26AM ET on Tuesday Jun 11, 2024 by MT Newswires
  Companies Mentioned: ABBV, ALVO
Jun 10, 2024
- AstraZeneca's Tagrisso Secures Priority Review in the US, from 7:09AM ET on Monday Jun 10, 2024 by MT Newswires
  7:09AM ET on Monday Jun 10, 2024 by MT Newswires
  Companies Mentioned: AZN
- --Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating, from 6:39AM ET on Monday Jun 10, 2024 by MT Newswires
  6:39AM ET on Monday Jun 10, 2024 by MT Newswires
  Companies Mentioned: AZN
Jun 6, 2024
- AbbVie Says Mid-Stage Study of Mirvetuximab Soravtansine to Treat Ovarian Cancer Meets Primary Endpoint, from 9:13AM ET on Thursday Jun 06, 2024 by MT Newswires
  9:13AM ET on Thursday Jun 06, 2024 by MT Newswires
  Companies Mentioned: ABBV
Jun 5, 2024
- AbbVie Says First Patient Treated in Phase 3 Trial Assessing Potential Blood Cancer Treatment, from 10:03AM ET on Wednesday Jun 05, 2024 by MT Newswires
  10:03AM ET on Wednesday Jun 05, 2024 by MT Newswires
  Companies Mentioned: ABBV

Eli Lilly and Co
NYSE:LLYUnited States

Search Criteria

Jun 14, 2024

DJ Gilead Stock Gains. It's Trying to Get Into the Obesity Drug Game. -- Barrons.com, from 2:27PM ET on Friday Jun 14, 2024 by Dow Jones

Jun 13, 2024

DJ Lilly's Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP. -- WSJ, from 9:51PM ET on Thursday Jun 13, 2024 by Dow Jones

DJ Lilly's Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP. -- WSJ, from 9:00PM ET on Thursday Jun 13, 2024 by Dow Jones

Jun 12, 2024

Eli Lilly Gets FDA Approval for Selpercatinib to Treat Thyroid Cancer, from 3:47PM ET on Wednesday Jun 12, 2024 by MT Newswires

Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan, from 1:53PM ET on Wednesday Jun 12, 2024 by MT Newswires

Peers Headlines

Today

CALQUENCE(R) (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial, from 12 hours ago by Business Wire

Jun 14, 2024

AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer, from 4:37PM ET on Friday Jun 14, 2024 by MT Newswires

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading, from 11:15AM ET on Friday Jun 14, 2024 by MT Newswires

Jun 13, 2024

AbbVie, FutureGen to Develop Potential Inflammatory Bowel Disease Treatment, from 8:44AM ET on Thursday Jun 13, 2024 by MT Newswires

Jun 12, 2024

AstraZeneca Gets FDA Approval for Pediatric Type-2 Diabetes Control Drug, from 4:00PM ET on Wednesday Jun 12, 2024 by MT Newswires

Jun 11, 2024

Alvotech Expands Alliance with STADA to Include Denosumab Biosimilar, from 5:26AM ET on Tuesday Jun 11, 2024 by MT Newswires

Jun 10, 2024

AstraZeneca's Tagrisso Secures Priority Review in the US, from 7:09AM ET on Monday Jun 10, 2024 by MT Newswires

--Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating, from 6:39AM ET on Monday Jun 10, 2024 by MT Newswires

Jun 6, 2024

AbbVie Says Mid-Stage Study of Mirvetuximab Soravtansine to Treat Ovarian Cancer Meets Primary Endpoint, from 9:13AM ET on Thursday Jun 06, 2024 by MT Newswires

Jun 5, 2024

AbbVie Says First Patient Treated in Phase 3 Trial Assessing Potential Blood Cancer Treatment, from 10:03AM ET on Wednesday Jun 05, 2024 by MT Newswires